On Wednesday, UAE Health health ministry said China’s Sinopharm coronavirus vaccine has 86% efficacy against the virus, citing an interim analysis of a human trial underway there.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
The ministry said: “The analysis shows no serious safety concerns.”
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
It did not say what side effects or illnesses participants experienced or how many volunteers were given the vaccine and how many received a placebo.
